Insurer’s historical illegal conduct in the US not significant, they say.
Tim Hunter Thu, 27 Sep 2018
The heads of the Reserve Bank and the Financial Markets Authority have defended their handling of insurer CBL’s licensing and float in light of the company’s extraordinary implosion.
NZX-listed CBL, valued by the market at $747 million before its shares were suspended in February, was hit by
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
